19th Nov 2025 07:00
Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Director/PDMR Shareholding
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 150,000 ordinary shares of 4 pence each in the Company ("Ordinary Shares"), at an average price of 2.32 pence each. Jeremy Millard, Non-Executive Director of the Company, has also purchased 168,776 Ordinary Shares in the Company, at a price of 2.37 pence each.
A summary of Carolyn Rand and Jeremy Millard's resultant holdings is below:
Director | Board Position | Number of Ordinary Shares acquired | Total beneficial holding of Ordinary Shares following this acquisition | |
Number of Ordinary Shares | Approximate % of Company's issued share capital | |||
Carolyn Rand | Non-Executive Chair | 150,000 | 347,500 | 0.14% |
Jeremy Millard | Non-Executive Director | 168,776 | 1,193,776 | 0.50% |
Contacts:
Cambridge Nutritional Sciences plc | www.cnsplc.com | |||
Carolyn Rand, Non-Executive Chair | ||||
James Cooper, Interim Chief Executive | ||||
Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |||
Geoff Nash / Edward Whiley (Corporate Finance) | ||||
Nigel Birks / Harriet Ward (ECM) | ||||
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Carolyn Rand | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | Non-Executive Chair | ||||||
b)
| Initial notification /Amendment
| Initial Notification | ||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Cambridge Nutritional Sciences plc | ||||||
b) | LEI | 2138007U9P4BTZTYIR92 | ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of 4 pence each
ISIN: GB00B1VCP282 | ||||||
b)
| Nature of the transaction | Ordinary Shares purchased | ||||||
c) | Price(s) and volume(s) |
| ||||||
d)
| Aggregated information
-Aggregated volume
- Price |
Aggregated volume - 150,000
Price - 2.3216 | ||||||
e)
| Date of the transaction | 18.11.2025 | ||||||
f)
| Place of the transaction | London Stock Exchange | ||||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Jeremy Millard | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-Executive Director | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Cambridge Nutritional Sciences plc | ||||
b) | LEI | 2138007U9P4BTZTYIR92 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of 4 pence each
ISIN: GB00B1VCP282 | ||||
b)
| Nature of the transaction | Ordinary Shares purchased | ||||
c) | Price(s) and volume(s) |
| ||||
d)
| Aggregated information
-Aggregated volume
- Price |
As above. | ||||
e)
| Date of the transaction | 18.11.2025 | ||||
f)
| Place of the transaction | London Stock Exchange | ||||
Related Shares:
Cambr Nutri Sci